PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
- Status
- RECRUITING
- Phase
- NA
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
- Status
- RECRUITING
- Phase
- NA
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT
- Status
- COMPLETED
- Phase
- NA
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Isa-Pom-Dex in Elderly/Frail Subjects With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CAR T-cell Therapy in Patients With Renal Dysfunction
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China
- Status
- COMPLETED
- Phase
- PHASE1
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
- Status
- COMPLETED
- Phase
- N/A
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Status
- RECRUITING
- Phase
- N/A
Integrated Actionable Aging Assessment for Cancer Patients Pilot
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Discontinuation Study
- Status
- RECRUITING
- Phase
- NA